Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

SITC 2021 | Should cancer patients undergoing immunotherapy get the COVID-19 vaccination?

Hannah E. Dzimitrowicz • 13 Nov 2021
SITC 2021
General

Hannah E. Dzimitrowicz, MD, Duke Cancer Center, Durham, NC, discusses the recommendation by several large oncology organisations, including the American Society of Clinical Oncology (ASCO) and the European Society for Medical Oncology (ESMO), for cancer patients undergoing immunotherapy treatment to get the COVID-19 vaccination. This interview took place during the 36th Society for Immunotherapy of Cancer (SITC) Annual Meeting in Washington, D.C.

More from Hannah E. Dzimitrowicz

0:48
Clinical activity of cabozantinib in patients with RCC with brain metastases
Hannah E. Dzimitrowicz • 13 Nov 2021
2:13
COVID-19 vaccination in patients with RCC and melanoma treated with immune checkpoint inhibitors
Hannah E. Dzimitrowicz • 13 Nov 2021
0:28
Future research on COVID-19 vaccine for patients with cancer
Hannah E. Dzimitrowicz • 13 Nov 2021

Related Videos

2:03
Biomarker detection for early cancer detection
Robert Rintoul • 19 Apr 2024
0:29
Innovative ctDNA-based liquid biopsy techniques for cancer diagnosis
Alain Thierry • 9 Apr 2024
0:50
Employing fragmentomics as a novel strategy to characterize and detect cancers
Alain Thierry • 9 Apr 2024
1:27
Emerging trials in melanoma: SWOG S1801, OpACIN-neo and PRADO
Christoffer Gebhardt • 9 Apr 2024
The content of VJOncology is intended for healthcare professionals